KETODOLOR 100 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, PIGS

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv ingrediens:

KETOPROFEN

Tilgjengelig fra:

Le Vet Beheer B.V.

ATC-kode:

QM01AE03

INN (International Name):

KETOPROFEN

Dosering :

100 Mg/Ml

Legemiddelform:

Solution for Injection

Resept typen:

POM

Terapeutisk gruppe:

Bovine, Equine - Food, Porcine

Terapeutisk område:

Ketoprofen

Indikasjoner:

N.S.A.I.D

Autorisasjon status:

Authorised

Autorisasjon dato:

2013-05-17

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ketodolor 100 mg/ml solution for injection for horses, cattle, pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, cattle, pigs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Horses:_
-
alleviation of inflammation and pain associated with musculoskeletal
disorders
-
alleviation of visceral pain associated with colic.
_Cattle:_
-
alleviation of pain (e.g. from pressure trauma) resulting from
parturient paresis;
-
reducing the pyrexia and distress associated with bacterial
respiratory disease when used in conjunction with
antimicrobial therapy as appropriate;
-
improving the recovery rate in acute clinical mastitis, including
acute endotoxin mastitis, caused by gram
negative micro-organisms, in conjunction with antimicrobial therapy;
-
alleviation of pain associated with udder oedema following calving.
-
reducing pain associated with lameness.
_Pigs:_
-
reducing the pyrexia and respiratory rate associated with bacterial or
viral respiratory disease when used in
conjunction with antimicrobial therapy as appropriate.
-
the supportive treatment of Mastitis Metritis Agalactia Syndrome in
sows, in conjunction with antimicrobial
therapy as appropriate.
Each ml contains:
ACTIVE SUBSTANCE:
Ketoprofen
100 mg
EXCIPIENTS:
Benzyl alcohol (E1519)
10
mg
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D